These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1263 related items for PubMed ID: 16289096

  • 41. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P, Song JH, Song DK, Zhang J, Hao C.
    Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
    [Abstract] [Full Text] [Related]

  • 42. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis.
    Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalò P, Oriente F, Miele C, Caruso M, Formisano P, Beguinot F.
    Oncogene; 1999 Aug 05; 18(31):4409-15. PubMed ID: 10442631
    [Abstract] [Full Text] [Related]

  • 43. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV, Rokhlin OW, Taghiyev AF, Cohen MB.
    Breast Cancer Res Treat; 2008 Feb 05; 107(3):349-57. PubMed ID: 17453339
    [Abstract] [Full Text] [Related]

  • 44. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.
    Vondrácek J, Soucek K, Sheard MA, Chramostová K, Andrysík Z, Hofmanová J, Kozubík A.
    Leuk Res; 2006 Jan 05; 30(1):81-9. PubMed ID: 15998540
    [Abstract] [Full Text] [Related]

  • 45. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short).
    Salon C, Eymin B, Micheau O, Chaperot L, Plumas J, Brambilla C, Brambilla E, Gazzeri S.
    Cell Death Differ; 2006 Feb 05; 13(2):260-72. PubMed ID: 16052233
    [Abstract] [Full Text] [Related]

  • 46. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL.
    Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K, Budach W.
    Oncogene; 2001 Apr 19; 20(17):2190-6. PubMed ID: 11360204
    [Abstract] [Full Text] [Related]

  • 47. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N, Hughes M, MacFarlane M, Cohen GM.
    J Biol Chem; 2003 Jul 11; 278(28):25534-41. PubMed ID: 12721308
    [Abstract] [Full Text] [Related]

  • 48. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N, Thornhill MH.
    Oral Oncol; 2008 Jul 11; 44(7):672-82. PubMed ID: 17996489
    [Abstract] [Full Text] [Related]

  • 49. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J, Cado D, Chen A, Kabra NH, Winoto A.
    Nature; 1998 Mar 19; 392(6673):296-300. PubMed ID: 9521326
    [Abstract] [Full Text] [Related]

  • 50. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha.
    Schaub FJ, Liles WC, Ferri N, Sayson K, Seifert RA, Bowen-Pope DF.
    Circ Res; 2003 Sep 19; 93(6):515-22. PubMed ID: 12946945
    [Abstract] [Full Text] [Related]

  • 51. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries.
    Manabe N, Matsuda-Minehata F, Goto Y, Maeda A, Cheng Y, Nakagawa S, Inoue N, Wongpanit K, Jin H, Gonda H, Li J.
    Reprod Domest Anim; 2008 Jul 19; 43 Suppl 2():268-72. PubMed ID: 18638134
    [Abstract] [Full Text] [Related]

  • 52. Polyomavirus large T-antigen protects mouse cells from Fas-, TNF-alpha- and taxol-induced apoptosis.
    Rodier F, Bertrand R, Bossolasco M, Mes-Masson AM.
    Oncogene; 2000 Dec 14; 19(54):6261-70. PubMed ID: 11175340
    [Abstract] [Full Text] [Related]

  • 53. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells.
    Siegmund D, Klose S, Zhou D, Baumann B, Röder C, Kalthoff H, Wajant H, Trauzold A.
    Cell Signal; 2007 Jun 14; 19(6):1172-84. PubMed ID: 17291719
    [Abstract] [Full Text] [Related]

  • 54. Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.
    Inoue S, MacFarlane M, Harper N, Wheat LM, Dyer MJ, Cohen GM.
    Cell Death Differ; 2004 Dec 14; 11 Suppl 2():S193-206. PubMed ID: 15608694
    [Abstract] [Full Text] [Related]

  • 55. The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway.
    Sancho R, de la Vega L, Appendino G, Di Marzo V, Macho A, Munoz E.
    Br J Pharmacol; 2003 Nov 14; 140(6):1035-44. PubMed ID: 14530215
    [Abstract] [Full Text] [Related]

  • 56. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H.
    J Biol Chem; 2001 Aug 31; 276(35):32585-90. PubMed ID: 11384965
    [Abstract] [Full Text] [Related]

  • 57. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of Fas-induced apoptosis by Bcl-2.
    Kawahara A, Kobayashi T, Nagata S.
    Oncogene; 1998 Nov 19; 17(20):2549-54. PubMed ID: 9840917
    [Abstract] [Full Text] [Related]

  • 59. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S, Vega M, Garban H, Bonavida B.
    Clin Immunol; 2006 Sep 19; 120(3):297-309. PubMed ID: 16784892
    [Abstract] [Full Text] [Related]

  • 60. Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms.
    Blomberg J, Ruuth K, Santos D, Lundgren E.
    Anticancer Res; 2008 Sep 19; 28(2A):593-9. PubMed ID: 18506997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 64.